Annual Retained Earnings:
-$7.29B-$278.16M(-3.97%)Summary
- As of today, ALNY annual retained earnings is -$7.29 billion, with the most recent change of -$278.16 million (-3.97%) on December 31, 2024.
- During the last 3 years, ALNY annual retained earnings has fallen by -$1.85 billion (-34.01%).
- ALNY annual retained earnings is now -162391.59% below its all-time high of -$4.49 million, reached on December 31, 2002.
Performance
ALNY Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
-$7.41B-$66.28M(-0.90%)Summary
- As of today, ALNY quarterly retained earnings is -$7.41 billion, with the most recent change of -$66.28 million (-0.90%) on June 30, 2025.
- Over the past year, ALNY quarterly retained earnings has dropped by -$319.09 million (-4.50%).
- ALNY quarterly retained earnings is now -25008.42% below its all-time high of -$29.52 million, reached on December 31, 2003.
Performance
ALNY Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ALNY Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -4.0% | -4.5% |
| 3Y3 Years | -34.0% | -24.4% |
| 5Y5 Years | -95.5% | -81.3% |
ALNY Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -34.0% | at low | -16.5% | at low |
| 5Y | 5-Year | -95.5% | at low | -70.7% | at low |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | at low |
ALNY Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -$7.41B(-0.9%) |
| Mar 2025 | - | -$7.35B(-0.8%) |
| Dec 2024 | -$7.29B(-4.0%) | -$7.29B(-1.2%) |
| Sep 2024 | - | -$7.20B(-1.6%) |
| Jun 2024 | - | -$7.09B(-0.2%) |
| Mar 2024 | - | -$7.08B(-0.9%) |
| Dec 2023 | -$7.01B(-6.7%) | -$7.01B(-2.0%) |
| Sep 2023 | - | -$6.87B(+2.1%) |
| Jun 2023 | - | -$7.02B(-4.1%) |
| Mar 2023 | - | -$6.74B(-2.7%) |
| Dec 2022 | -$6.57B(-20.8%) | -$6.57B(-3.3%) |
| Sep 2022 | - | -$6.36B(-6.8%) |
| Jun 2022 | - | -$5.96B(-4.9%) |
| Mar 2022 | - | -$5.68B(-4.4%) |
| Dec 2021 | -$5.44B(-18.6%) | -$5.44B(-5.0%) |
| Sep 2021 | - | -$5.18B(-4.1%) |
| Jun 2021 | - | -$4.98B(-4.0%) |
| Mar 2021 | - | -$4.79B(-4.4%) |
| Dec 2020 | -$4.59B(-23.0%) | -$4.59B(-5.6%) |
| Sep 2020 | - | -$4.34B(-6.2%) |
| Jun 2020 | - | -$4.09B(-4.6%) |
| Mar 2020 | - | -$3.91B(-4.9%) |
| Dec 2019 | -$3.73B(-31.2%) | -$3.73B(-8.0%) |
| Sep 2019 | - | -$3.45B(-6.4%) |
| Jun 2019 | - | -$3.24B(-7.3%) |
| Mar 2019 | - | -$3.02B(-6.4%) |
| Dec 2018 | -$2.84B(-32.3%) | -$2.84B(-8.0%) |
| Sep 2018 | - | -$2.63B(-10.3%) |
| Jun 2018 | - | -$2.38B(-7.4%) |
| Mar 2018 | - | -$2.22B(-3.4%) |
| Dec 2017 | -$2.15B(-29.6%) | -$2.15B(-7.1%) |
| Sep 2017 | - | -$2.01B(-6.5%) |
| Jun 2017 | - | -$1.88B(-6.7%) |
| Mar 2017 | - | -$1.76B(-6.5%) |
| Dec 2016 | -$1.66B(-32.9%) | -$1.66B(-7.3%) |
| Sep 2016 | - | -$1.54B(-7.2%) |
| Jun 2016 | - | -$1.44B(-6.7%) |
| Mar 2016 | - | -$1.35B(-8.3%) |
| Dec 2015 | -$1.25B(-30.3%) | -$1.25B(-7.8%) |
| Sep 2015 | - | -$1.16B(-7.1%) |
| Jun 2015 | - | -$1.08B(-7.1%) |
| Mar 2015 | - | -$1.01B(-5.3%) |
| Dec 2014 | -$956.63M | -$956.63M(-2.3%) |
| Sep 2014 | - | -$935.24M(-4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | -$891.25M(-5.2%) |
| Mar 2014 | - | -$847.18M(-42.1%) |
| Dec 2013 | -$596.24M(-17.6%) | -$596.24M(-5.7%) |
| Sep 2013 | - | -$563.88M(-5.6%) |
| Jun 2013 | - | -$534.19M(-3.5%) |
| Mar 2013 | - | -$516.02M(-1.8%) |
| Dec 2012 | -$507.01M(-26.4%) | -$507.01M(-14.0%) |
| Sep 2012 | - | -$444.82M(-4.6%) |
| Jun 2012 | - | -$425.32M(-3.1%) |
| Mar 2012 | - | -$412.36M(-2.8%) |
| Dec 2011 | -$401.00M(-16.8%) | -$401.00M(-3.7%) |
| Sep 2011 | - | -$386.69M(-3.5%) |
| Jun 2011 | - | -$373.46M(-3.8%) |
| Mar 2011 | - | -$359.63M(-4.7%) |
| Dec 2010 | -$343.35M(-14.5%) | -$343.35M(-2.1%) |
| Sep 2010 | - | -$336.42M(-2.9%) |
| Jun 2010 | - | -$326.79M(-4.7%) |
| Mar 2010 | - | -$312.15M(-4.1%) |
| Dec 2009 | -$299.83M(-18.9%) | -$299.83M(-2.7%) |
| Sep 2009 | - | -$292.04M(-3.3%) |
| Jun 2009 | - | -$282.83M(-8.7%) |
| Mar 2009 | - | -$260.13M(-3.1%) |
| Dec 2008 | -$252.24M(-11.6%) | -$252.24M(-3.9%) |
| Sep 2008 | - | -$242.85M(-1.2%) |
| Jun 2008 | - | -$239.99M(-5.6%) |
| Mar 2008 | - | -$227.23M(-0.5%) |
| Dec 2007 | -$225.99M(-60.8%) | -$225.99M(+0.7%) |
| Sep 2007 | - | -$227.66M(-30.2%) |
| Jun 2007 | - | -$174.86M(-7.8%) |
| Mar 2007 | - | -$162.17M(-15.4%) |
| Dec 2006 | -$140.53M(-32.7%) | -$140.53M(-6.4%) |
| Sep 2006 | - | -$132.09M(-5.9%) |
| Jun 2006 | - | -$124.69M(-8.6%) |
| Mar 2006 | - | -$114.78M(-8.4%) |
| Dec 2005 | -$105.92M(-68.1%) | -$105.92M(-15.8%) |
| Sep 2005 | - | -$91.43M(-13.2%) |
| Jun 2005 | - | -$80.75M(-16.0%) |
| Mar 2005 | - | -$69.60M(-10.5%) |
| Dec 2004 | -$63.01M(-113.4%) | -$63.01M(-9.9%) |
| Sep 2004 | - | -$57.30M(-12.6%) |
| Jun 2004 | - | -$50.89M(-15.8%) |
| Mar 2004 | - | -$43.93M(-48.8%) |
| Dec 2003 | -$29.52M(-558.1%) | -$29.52M |
| Dec 2002 | -$4.49M | - |
FAQ
- What is Alnylam Pharmaceuticals, Inc. annual retained earnings?
- What is the all-time high annual retained earnings for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. annual retained earnings year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. quarterly retained earnings?
- What is the all-time high quarterly retained earnings for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
What is Alnylam Pharmaceuticals, Inc. annual retained earnings?
The current annual retained earnings of ALNY is -$7.29B
What is the all-time high annual retained earnings for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high annual retained earnings is -$4.49M
What is Alnylam Pharmaceuticals, Inc. annual retained earnings year-on-year change?
Over the past year, ALNY annual retained earnings has changed by -$278.16M (-3.97%)
What is Alnylam Pharmaceuticals, Inc. quarterly retained earnings?
The current quarterly retained earnings of ALNY is -$7.41B
What is the all-time high quarterly retained earnings for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high quarterly retained earnings is -$29.52M
What is Alnylam Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
Over the past year, ALNY quarterly retained earnings has changed by -$319.09M (-4.50%)